NCT06246409

Brief Summary

Daily patient participation is critical to the successful, life-saving delivery of radiotherapy. There is very little in the literature describing the best way to prepare patients to give optimal participation. This study aims to look at an already-prepared conversion of patient instruction materials and measure whether the improvement in clarity and specificity produces the desired changes in patient decision-making and emotional comfort.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
650

participants targeted

Target at P75+ for not_applicable cancer

Timeline
6mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Dec 2024Dec 2026

First Submitted

Initial submission to the registry

January 30, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 7, 2024

Completed
11 months until next milestone

Study Start

First participant enrolled

December 24, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

1.9 years

First QC Date

January 30, 2024

Last Update Submit

March 3, 2026

Conditions

Keywords

patient comfortpatient participationexternal beam radiotherapyradiation oncology

Outcome Measures

Primary Outcomes (1)

  • Unintentional missed treatment days

    Determine the number of unintentional missed days of treatment during a course of radiotherapy

    8 weeks

Secondary Outcomes (6)

  • Patient-reported comfort

    8 weeks

  • Unplanned clinic visits

    8 weeks

  • Emergency department visits

    8 weeks

  • Hospitalizations

    8 weeks

  • Rate of treatment completion

    8 weeks

  • +1 more secondary outcomes

Study Arms (2)

Arm 1: Existing patient instructions

ACTIVE COMPARATOR
Behavioral: Existing patient instructions

Arm 2: Modernized patient instructions

EXPERIMENTAL
Behavioral: Modernized patient instructions

Interventions

Patients will be given modernized patient instructions prior to radiotherapy treatment.

Arm 2: Modernized patient instructions

Patients will be given the patient instructions currently in use prior to radiotherapy treatment.

Arm 1: Existing patient instructions

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥ 18 years old planning their first external beam radiotherapy
  • Written informed consent obtained from the subject and the subject agrees to comply with all the study-related procedures.

You may not qualify if:

  • Have received external beam radiotherapy in the past
  • External beam radiotherapy is initiated as inpatient.
  • External beam radiotherapy consists of less than 3 fractions.
  • Planned radiotherapy that does not employ an external beam
  • Planned participation in a clinical study that prohibits participation in a second, concurrent treatment trial
  • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida

Gainesville, Florida, 32608, United States

RECRUITING

MeSH Terms

Conditions

NeoplasmsPatient Participation

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Alexandra De Leo, MD

    University of Florida

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 7, 2024

Study Start

December 24, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

March 4, 2026

Record last verified: 2026-03

Locations